Elite Vigilance

Pharmacovigilance with Purpose and Precision

Pharmacovigilance Built on Compliance

Pharmacovigilance Driven by Expertise and Automation

Pharmacovigilance with Purpose and Precision

Background Shape
Dots
Underline

Elite Vigilance brings together deep pharmacovigilance expertise and a commitment to drug safety excellence. We work alongside pharmaceutical and biotech organisations throughout the product journey, ensuring every safety signal is captured, every report meets regulatory standards, and patient welfare remains central. Our approach combines rigorous scientific understanding with practical regulatory knowledge, giving our partners confidence that their safety operations are thorough, transparent, and built on a foundation of integrity.

Underline

Elite Vigilance delivers pharmacovigilance services through clearly defined processes designed to support regulatory expectations across global and regional frameworks. Our approach emphasises structured workflows, robust documentation, and integrated quality oversight, ensuring safety activities remain consistent, traceable, and inspection-ready. By aligning operational practice with internationally recognised guidelines and local regulatory requirements, we help organisations maintain reliable safety systems throughout the product lifecycle.

Underline

Elite Vigilance combines deep pharmacovigilance expertise with intelligent automation to support accurate, scalable safety operations. Our teams bring hands-on experience across global PV lifecycles, while AI-enabled workflows improve efficiency, consistency, and data handling. Beyond using established platforms, we design and build automation aligned with real-world pharmacovigilance processes—ensuring regulatory compliance, operational clarity, and expert-led oversight at every stage.

Underline

Elite Vigilance brings together deep pharmacovigilance expertise and a commitment to drug safety excellence. We work alongside pharmaceutical and biotech organisations throughout the product journey, ensuring every safety signal is captured, every report meets regulatory standards, and patient welfare remains central. Our approach combines rigorous scientific understanding with practical regulatory knowledge, giving our partners confidence that their safety operations are thorough, transparent, and built on a foundation of integrity.

Lookingfor the PV services
WorriedAbout High Costs?
NeedFully Compliant System?
Let's Manage Your PV System

About Elite Vigilance

Elite Vigilance is an independent pharmacovigilance service provider supporting pharmaceutical, and biotechnology organisations across regulated global markets. We specialise in building reliable, compliant, and well-governed safety systems aligned with international standards and country-specific regulatory requirements.

Our delivery model is intentionally flexible, offering long-term partnerships as well as on-demand expert support to meet evolving safety needs. Technology-enabled workflows and automation support efficiency, accuracy, and scalability across key PV activities, while maintaining regulatory and quality expectations.

Grounded in structured processes, strong documentation, and integrated quality oversight, our operations remain transparent and inspection-ready. With deep subject-matter expertise and practical regulatory understanding, we work closely with clients to deliver sustainable, dependable pharmacovigilance solutions focused on patient safety and regulatory clarity.

Metrics

98–100%

Regulatory Compliance

15+ Years

Of Combined PV Expertise

<1%

Error Rate in Quality Checks

24/7

Availability Through Flexible Models

Global Standards& RegulatoryCompliance

Aligned with international pharmacovigilance standards and regional regulatory requirements worldwide.

Our platform supports end-to-end pharmacovigilance operations while meeting international regulatory expectations. From case processing to signal management, every workflow is designed for compliance.

ICH

ICH

Globally harmonised pharmacovigilance standards.

EMA

EMA

European pharmacovigilance regulatory alignment.

FDA

FDA

United States safety reporting requirements.

MHRA

MHRA

Compliant with UK medicines and safety oversight framework.

INDIA

INDIA

Supporting national ADR reporting requirements.

Our Pharmacovigilance Approach

Our approach to pharmacovigilance is built around a series of coordinated activities that work together to maintain reliable safety oversight. Rather than isolated tasks, each part of our workflow contributes to a cohesive system focused on regulatory alignment, clear communication, and responsible safety management across the product lifecycle.

AI Robot

Pharmacovigilance
At The Speed Of Thought,
Powered By AI

At Elite Vigilance, AI-enabled tools are applied to support pharmacovigilance teams by easing operational complexity across defined safety activities. Technology is used to assist data handling, workflow coordination, and process consistency, helping improve efficiency and reduce manual burden. These tools operate within controlled pharmacovigilance frameworks, while medical evaluation, regulatory judgement, and safety decision-making remain firmly under the oversight of experienced pharmacovigilance professionals.

Improved Accuracy

AI-supported processes help reduce manual inconsistencies by enhancing structured data handling, standardising case workflows, and supporting consistent management of safety information across pharmacovigilance activities.

Improved Accuracy

Enhanced Efficiency

By supporting repetitive and process-driven tasks, AI enables smoother pharmacovigilance operations and improved utilisation of expert resources, while maintaining appropriate oversight and alignment with regulatory expectations.

Enhanced Efficiency

Reduced Operational Burden

Streamlined, AI-assisted workflows reduce operational effort and resource strain, enabling efficient and sustainable pharmacovigilance delivery while maintaining quality standards, regulatory discipline, and clear accountability.

Reduced Operational Burden

What Sets Elite Vigilance Apart

A simple, proven process to transform your pharmacovigilance

Regulatory & Safety Assessment

Regulatory & Safety Assessment

We begin by understanding the product profile, regulatory landscape, and existing safety systems to define pharmacovigilance responsibilities aligned with applicable global and regional requirements.

Structured Safety Operations

Structured Safety Operations

Pharmacovigilance activities are executed through defined processes, documented workflows, and quality oversight to ensure consistency, traceability, and ongoing regulatory compliance.

Continuous Oversight & Support

Continuous Oversight & Support

Safety systems are maintained through ongoing monitoring, periodic review, and regulatory alignment to support long-term pharmacovigilance obligations and evolving compliance expectations.

Our Methodology

Elite Vigilance brings together deep pharmacovigilance expertise and a commitment to drug safety excellence.

Submit Your Requirements

Tell us about your PV challenges, volume, and goals. We'll listen carefully.

Get Custom Solution

Our experts design a tailored solution combining AI tools and services.

Seamless Implementation

We handle integration, training, and go-live with zero disruption.

Ongoing Partnership

24/7 support, continuous optimization, and strategic guidance.

Voices of Trust

Elite Vigilance brings together deep pharmacovigilance expertise and a commitment to drug safety excellence.

User
Quote

They caught an error in our SOP that could have caused problems during inspection. Didn't bill us extra, didn't make a big deal about it, just flagged it during onboarding and helped us fix it. That attention to detail and genuine interest in our success made me confident we'd chosen the right partner.

Quote Bottom
User
Quote

Elite Vigilance supported us during a critical phase of our pharmacovigilance setup. Their independent perspective, attention to detail, and structured processes helped us maintain confidence in our safety systems.

Quote Bottom
User
Quote

We switched to Elite Vigilance after a frustrating year with another provider who treated us like just another account number. The difference was immediate. They actually read our products' clinical trial data before processing cases. When a complex report came in, their medical reviewer called me to discuss it rather than just making assumptions. That level of engagement is rare. It's been 18 months and I genuinely enjoy our weekly calls, which says something because pharmacovigilance meetings aren't usually the highlight of anyone's week

Quote Bottom
User
Quote

What stood out was their ability to align safety activities with both global and local regulatory expectations. Communication was clear, documentation was consistent, and the team showed a practical understanding of real-world pharmacovigilance challenges.

Quote Bottom
User
Quote

They caught an error in our SOP that could have caused problems during inspection. Didn't bill us extra, didn't make a big deal about it, just flagged it during onboarding and helped us fix it. That attention to detail and genuine interest in our success made me confident we'd chosen the right partner.

Quote Bottom
User
Quote

Elite Vigilance supported us during a critical phase of our pharmacovigilance setup. Their independent perspective, attention to detail, and structured processes helped us maintain confidence in our safety systems.

Quote Bottom

FAQ's

Yes, safety monitoring requirements span the entire product lifecycle but look different at each stage. During clinical development, the focus is on rapid reporting of serious adverse events, maintaining trial safety databases, and preparing development safety reports. Post-approval, you're managing spontaneous reports from healthcare providers and patients, conducting periodic benefit-risk evaluations, and maintaining post-authorization safety studies if required. Experienced providers adapt their approach based on your product's development stage and specific regulatory obligations.

Yes, and this is actually one area where experienced providers add significant value. Different regions have different requirements—the EU has its Good Pharmacovigilance Practices, the FDA has its own guidelines, and emerging markets each have local regulations. A good partner maintains local qualified persons where needed, understands regional reporting formats and timelines, and keeps current with regulatory changes across all your markets.

Onboarding timelines vary based on complexity, but typically range from 4–12 weeks. For companies with multiple products or complex therapeutic areas, it might take longer. The key is not rushing—proper onboarding prevents mistakes down the line. A good partner will provide a detailed transition plan with milestones, so you know exactly what to expect and when full operations begin.

Medical writing in pharmacovigilance isn't just summarising data—it requires scientific expertise and regulatory knowledge. Writers prepare documents like Development Safety Update Reports, Periodic Benefit-Risk Evaluation Reports, Risk Management Plans (RMPs), and responses to health authority questions. Each has specific format requirements and must present complex safety data clearly and accurately.

Regulations evolve constantly—new guidelines, updated reporting formats, changing timelines. Professional pharmacovigilance teams attend regulatory conferences, monitor health authority publications, participate in ongoing training, and maintain industry memberships. This ensures rapid implementation of regulatory updates and continued compliance.

Absolutely. As you launch new products, expand into new markets, or experience increased case volumes, a strong pharmacovigilance partner can scale resources accordingly. This flexibility allows you to adapt without the burden of hiring and training internal teams.

Earlier is better. Ideally, engagement should occur during late-stage clinical development, before marketing authorisation. This allows sufficient time for onboarding, system setup, documentation preparation, and regulatory readiness.

Data security is critical. Reputable providers use encrypted data storage and transmission, strict access controls, regular audits, GDPR and HIPAA compliance, validated systems, and comprehensive staff training to ensure patient confidentiality and data integrity.